Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm?
- PMID: 17925872
- PMCID: PMC1995754
- DOI: 10.1371/journal.pone.0001024
Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm?
Abstract
Background: Hemolytic uremic syndrome (HUS) is caused by enterohemorrhagic Escherichia coli (EHEC) which possess genes encoding Shiga toxin (stx), the major virulence factor, and adhesin intimin (eae). However, the frequency of stx-negative/eae-positive E. coli in stools of HUS patients and the clinical significance of such strains are unknown.
Methodology/principal findings: Between 1996 and 2006, we sought stx-negative/eae-positive E. coli in stools of HUS patients using colony blot hybridization with the eae probe and compared the isolates to EHEC causing HUS. stx-negative/eae-positive E. coli were isolated as the only pathogens from stools of 43 (5.5%) of 787 HUS patients; additional 440 (55.9%) patients excreted EHEC. The majority (90.7%) of the stx-negative/eae-positive isolates belonged to serotypes O26:H11/NM (nonmotile), O103:H2/NM, O145:H28/NM, and O157:H7/NM, which were also the most frequent serotypes identified among EHEC. The stx-negative isolates shared non-stx virulence and fitness genes with EHEC of the corresponding serotypes and clustered with them into the same clonal complexes in multilocus sequence typing, demonstrating their close relatedness to EHEC.
Conclusions/significance: At the time of microbiological analysis, approximately 5% of HUS patients shed no longer the causative EHEC, but do excrete stx-negative derivatives of EHEC that lost stx during infection. In such patients, the EHEC etiology of HUS is missed using current methods detecting solely stx or Shiga toxin; this can hamper epidemiological investigations and lead to inappropriate clinical management. While maintaining the paradigm that HUS is triggered by Shiga toxin, our data demonstrate the necessity of considering genetic changes of the pathogen during infection to adapt appropriately diagnostic strategies.
Conflict of interest statement
Figures

Similar articles
-
Enterohemorrhagic Escherichia coli as causes of hemolytic uremic syndrome in the Czech Republic.PLoS One. 2013 Sep 6;8(9):e73927. doi: 10.1371/journal.pone.0073927. eCollection 2013. PLoS One. 2013. PMID: 24040117 Free PMC article.
-
Shiga Toxin-Producing Escherichia coli Infection in Jönköping County, Sweden: Occurrence and Molecular Characteristics in Correlation With Clinical Symptoms and Duration of stx Shedding.Front Cell Infect Microbiol. 2018 May 1;8:125. doi: 10.3389/fcimb.2018.00125. eCollection 2018. Front Cell Infect Microbiol. 2018. PMID: 29765909 Free PMC article.
-
Phenotypic and genotypic traits of Shiga toxin-negative E. coli O157:H7/H(-) bovine and porcine strains.Foodborne Pathog Dis. 2009 Mar;6(2):235-43. doi: 10.1089/fpd.2008.0205. Foodborne Pathog Dis. 2009. PMID: 19245340
-
Enterohaemorrhagic Escherichia coli O26:H11/H-: a human pathogen in emergence.Berl Munch Tierarztl Wochenschr. 2007 Jul-Aug;120(7-8):279-87. Berl Munch Tierarztl Wochenschr. 2007. PMID: 17715820 Review.
-
[Enterohemorrhagic Escherichia coli and hemolytic-uremic syndrome].Wien Klin Wochenschr. 1997 Sep 19;109(17):669-77. Wien Klin Wochenschr. 1997. PMID: 9381722 Review. German.
Cited by
-
Refining the pathovar paradigm via phylogenomics of the attaching and effacing Escherichia coli.Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):12810-5. doi: 10.1073/pnas.1306836110. Epub 2013 Jul 15. Proc Natl Acad Sci U S A. 2013. PMID: 23858472 Free PMC article.
-
Evaluation of CHROMagar STEC and STEC O104 chromogenic agar media for detection of Shiga Toxin-producing Escherichia coli in stool specimens.J Clin Microbiol. 2013 Mar;51(3):894-900. doi: 10.1128/JCM.03121-12. Epub 2013 Jan 2. J Clin Microbiol. 2013. PMID: 23284030 Free PMC article.
-
Recent advances in understanding enteric pathogenic Escherichia coli.Clin Microbiol Rev. 2013 Oct;26(4):822-80. doi: 10.1128/CMR.00022-13. Clin Microbiol Rev. 2013. PMID: 24092857 Free PMC article. Review.
-
Low-density macroarray targeting non-locus of enterocyte effacement effectors (nle genes) and major virulence factors of Shiga toxin-producing Escherichia coli (STEC): a new approach for molecular risk assessment of STEC isolates.Appl Environ Microbiol. 2010 Jan;76(1):203-11. doi: 10.1128/AEM.01921-09. Epub 2009 Oct 30. Appl Environ Microbiol. 2010. PMID: 19880649 Free PMC article.
-
Rapid MALDI-TOF mass spectrometry strain typing during a large outbreak of Shiga-Toxigenic Escherichia coli.PLoS One. 2014 Jul 8;9(7):e101924. doi: 10.1371/journal.pone.0101924. eCollection 2014. PLoS One. 2014. PMID: 25003758 Free PMC article.
References
-
- Tarr PI, Gordon CA, Chandler WL. Shiga toxin-producing Escherichia coli and the haemolytic uraemic syndrome. Lancet. 2005;365:1073–1086. - PubMed
-
- Karch H, Tarr PI, Bielaszewska M. Enterohaemorrhagic Escherichia coli in human medicine. Int J Med Microbiol. 2005;295:405–418. - PubMed
-
- Siegler RL. Postdiarrheal Shiga toxin-mediated hemolytic uremic syndrome. JAMA. 2003;290:1379–1381. - PubMed
-
- Gerber A, Karch H, Allerberger F, Verweyen HM, Zimmerhackl LB. Clinical course and the role of Shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997–2000, in Germany and Austria: a prospective study. J Infect Dis. 2002;186:493–500. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical